US2004242504A1PendingUtilityA1
Novel composition and method for the treatment of hypertension
Priority: May 30, 2003Filed: May 30, 2003Published: Dec 2, 2004
Est. expiryMay 30, 2023(expired)· nominal 20-yr term from priority
A61K 36/752A61K 45/06A23L 33/105A61K 33/34A61K 31/375A61K 33/04A61K 36/82A23V 2002/00A23L 33/16A61K 31/221A61K 31/401A61K 31/198A23L 33/175A61K 33/32A61K 33/06A61P 9/02A61K 31/7048A61K 31/352
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides for a composition and method of treatment and prevention of hypertension and its resulting complications comprising the step of administering to a patient a therapeutically-effective amount of Quercetin or Quercetin Glycoside and Epican Forte in therapeutic proportions.
Claims
exact text as granted — not AI-modifiedThe following is claimed:
1 . A method for treatment and/or prevention of hypertension comprising the step of administering to a patient a therapeutically-effective amount of Quercetin or Quercetin Glycosides, and Epican Forte, in therapeutic proportions.
2 . The method of claim 1 wherein Quercetin Glycoside is extracted from a plant source selected from the group of onions and apples.
3 . The method of claim 1 wherein the dose of Quercetin is equivalent to between approximately 100 mg and 15 grams on a daily basis.
4 . The method of claim 1 wherein the dose of Quercetin is equivalent to between approximately 1 grams and 10 grams on a daily basis.
5 . The method of claim 1 wherein the dose of Quercetin is repeated daily.
6 . The method of claim 1 , wherein the Quercetin is administered to a human as part of foods, drinks, health bars, bread or cereals.
7 . The method of claim 1 wherein Epican Forte is administered in daily amounts indicated in Table 1.
8 . A composition for use in treatment of hypertension in a patient susceptible or suffering from hypertension or its side effects, comprising of Quercetin or Quercetin Glycoside and Epican Forte in therapeutic amounts.
9 . The composition of claim 8 wherein Quercetin Glycoside is extracted from a plant source selected from the group of onions and apples.
10 . The composition of claim 8 wherein the dose of Quercetin or Quercetin Glycoside is equivalent to between approximately 100 mg and 15 grams on a daily basis.
11 . The composition of claim 8 wherein the dose of Quercetin or Quercetin Glycoside is equivalent to between approximately 1 grams and 10 grams on a daily basis.
12 . The composition of claim 8 wherein the dose of Quercetin or Quercetin Glycoside is repeated daily.
13 . The composition of claim 8 , wherein the Quercetin or Quercetin Glycoside is administered to a human as part of foods, drinks, health bars, bread or cereals.
14 . The composition of claim 8 wherein Epican Forte is administered in daily amounts indicated in Table 1.Join the waitlist — get patent alerts
Track US2004242504A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.